AI Summary
This article discusses the findings of a phase 4 trial showing that monthly erenumab can effectively and safely induce remission of nonopioid medication overuse headache in patients with chronic migraine.
Monthly erenumab induced remission of nonopioid medication overuse headache safely and effectively in patients with chronic migraine, a phase 4 trial found.
Medscape Medical News